CIK 0001561921 · Non-accelerated filer<br>Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455320061
- Phone
- 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $175,549
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$175,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-24 | Cuca Roberto COO and CFO | Purchase | +64,444 | $2.25 | $145K | 155,388 |
| 2024-10-24 | Talmo Paul Chief Technology Officer | Purchase | +22,222 | $2.25 | $50K | 91,082 |
| 2024-10-24 | KOBLISH ANTONY Chief Executive Officer | Purchase | +88,888 | $2.25 | $200K | 458,897 |
| 2024-10-24 | Firestone Gregory A. Chief Commercial Officer | Purchase | +6,666 | $2.25 | $15K | 57,279 |
| 2024-08-03 | Firestone Gregory A. Chief Commercial Officer | Shares withheld for taxes | −1,093 | $4.25 | $5K | 50,613 |
| 2024-07-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −36,600 | $4.54 | $166K | 2,407,242 |
| 2024-07-01 | ORBIMED ADVISORS LLC 10% owner | Sale | −13,700 | $4.68 | $64K | 2,443,842 |
| 2024-06-28 | ORBIMED ADVISORS LLC 10% owner | Sale | −378,000 | $4.74 | $1.8M | 2,457,542 |
| 2024-06-04 | EVANS DOUGLAS G Director | Grant or award | +4,250 | 10,520 | ||
| 2024-06-04 | EVANS DOUGLAS G Director | Grant or award · Stock Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-06-04 | Azarbarzin Kurt Director | Grant or award | +4,250 | 10,520 | ||
| 2024-06-04 | Azarbarzin Kurt Director | Grant or award · Stock Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-06-04 | COLLERAN LISA N Director | Grant or award | +4,250 | 10,520 | ||
| 2024-06-04 | COLLERAN LISA N Director | Grant or award · Stock Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-06-04 | Burgess Vincent J Director | Grant or award | +4,250 | 15,380 | ||
| 2024-06-04 | Burgess Vincent J Director | Grant or award · Stock Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-06-04 | O'Brien Federica F. Director | Grant or award | +4,250 | 10,520 | ||
| 2024-06-04 | O'Brien Federica F. Director | Grant or award · Stock Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-06-04 | Blizard Jeffrey Director | Grant or award | +6,375 | 6,375 | ||
| 2024-06-04 | Blizard Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +9,300 | 9,300 |
Page 6 of 12 · 237 trades